Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Novavax Inc. Stock

Price
Target price
€12.08

€12.08

1.600%
0.19
1.600%
€17.59
 
02.07.24 / Tradegate WKN: A2PKMZ / Symbol: NVAX / Name: Novavax / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Novavax Inc. in the next few years
Wizard

Novavax Inc. Stock

Novavax Inc. gained 1.600% today.
Our community is currently high on Novavax Inc. with 4 Buy predictions and 1 Sell predictions.
With a target price of 17 € there is a positive potential of 40.68% for Novavax Inc. compared to the current price of 12.08 €.
Our community identified positive and negative aspects for Novavax Inc. stock for the coming years. 10 users see the criterium "Worthwhile Investment for the next years" as a plus for the Novavax Inc. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
What does Novavax do?

Pros and Cons of Novavax Inc. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Novavax Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Novavax Inc. 1.600% -7.416% -12.852% 77.601% 170.638% -93.397% 133.102%
Ardelyx Inc. -31.220% -12.398% -22.159% 58.645% -14.913% -26.597% -
Evolus Inc 3.550% 5.155% -13.559% 58.140% 12.707% -2.857% -
Krystal Biotech -1.590% -1.928% 12.140% 53.102% 42.543% - -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-30

General Impression

The financials of Novavax, a Biotechnology & Medical Research company with US symbol NVAX, paint a mixed picture. Over the past few years, the company has reported a significant increase in its revenue and total assets. However, its net income has consistently been in the negative, and it has faced challenges in maintaining a positive net working capital and managing its liabilities.

Detailed Analysis

Show more

Comments

Prediction Buy
Perf. (%) -13.23%
Target price 26.761
Change
Ends at 23.05.25

Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at B. Riley from $11.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Show more

B. Riley 
0
Report Share
23.05.24
Prediction Buy
Perf. (%) 43.69%
Target price 17.592
Change
Ends at 13.05.25

Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Show more

HC Wainwright 
0
Report Share
13.05.24

Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for NVAX provided by MarketBeat
Show more

B. Riley 
0
Report Share
09.08.23 Buy 80.36%
Show more
Not a member yet? Sign up for free!

News

Where Will Novavax Be in 1 Year?: https://g.foolcdn.com/editorial/images/780292/person-getting-vaccinated.jpg
Where Will Novavax Be in 1 Year?

What a difference a few months make. Vaccine specialist Novavax (NASDAQ: NVAX) started the year poorly, continuing with the issues it has encountered since mid-2021.

Those headwinds included the

TheMotleyFool 
0 29.06.24
Is It Too Late to Buy Novavax Stock?: https://g.foolcdn.com/editorial/images/780099/stock-traders-looking-at-a-chart.jpg
Is It Too Late to Buy Novavax Stock?

Novavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive developments in recent months, including a deal with

TheMotleyFool 
0 14.06.24
Top 4 Large-Cap Stocks With Major Short Interest: https://www.marketbeat.com/logos/articles/med_20240612135212_top-4-large-cap-stocks-with-major-short-interest.jpg
Top 4 Large-Cap Stocks With Major Short Interest

With the ongoing GameStop saga reigniting interest in meme stocks, investors, or more likely traders and speculators, are once again seeking out stocks with high short interest. As the overall

MarketBeat 
0 13.06.24